Portal Biotech
@portalbiotech.bsky.social
Portal is revolutionising biosensing by bringing precise and universal nanopore-based proteomics and metabolomics solutions to the bench-top.
Portal Biotech Closes $35M Series A to Deliver First Full-Length Single-Molecule Protein Sequencer.
Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development & diagnostics. tinyurl.com/5y9cjbej #proteomics #nanopore
Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development & diagnostics. tinyurl.com/5y9cjbej #proteomics #nanopore
July 2, 2025 at 4:48 PM
Portal Biotech Closes $35M Series A to Deliver First Full-Length Single-Molecule Protein Sequencer.
Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development & diagnostics. tinyurl.com/5y9cjbej #proteomics #nanopore
Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development & diagnostics. tinyurl.com/5y9cjbej #proteomics #nanopore